INDUSTRY SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2013

INDUSTRY SEGMENT INFORMATION [Abstract]

Selected Financial Information by Industry Segment

Selected financial information by industry segment is presented below (in thousands).

	THREE MONTHS ENDED MARCH 31,
	2013			2012
REVENUES:
Ophthalmic	$	25,705		$	21,811
Hospital Drugs & Injectables		40,434			27,376
Contract Services		7,715			2,530
Total revenues	$	73,854		$	51,717
GROSS PROFIT:
Ophthalmic	$	14,716		$	12,719
Hospital Drugs & Injectables		22,814			17,041
Contract Services		1,615			1,141
Total gross profit		39,145			30,901
Operating expenses		20,556			23,239
Operating income		18,589			7,662
Other (expense) income		(2,332	)		(2,420	)
Income before income taxes	$	16,257		$	5,242

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details